Skip to Main Content
Table 3.

Risk factors for absence of health care utilization reported by HCT survivors

Risk factorsEntire cohort
Allogeneic HCT
Autologous HCT
GPECancer/HCT–related visitGPECancer/HCT–related visitGPECancer/HCT–related visit
Type of transplant       
    Autologous 1.00 1.00     
    Allogeneic 1.72 (1.1-2.6) 0.49 (0.3-0.9)     
Race       
    Non-Hispanic White  1.00  1.00   
    Hispanic White  0.23 (0.1-0.6)  0.16 (0.04-0.6)   
    Others  0.67 (0.3-1.7)  0.66 (0.2-2.1)   
Follow-up years       
    2-5 1.00 1.00 1.00 1.00  1.00 
    6-10 0.65 (0.5-0.9) 5.15 (2.7-9.7) 0.44 (0.3-0.8) 6.82 (1.9-24.5)  4.75 (2.3-10.1) 
    11+ 0.57 (0.4-0.9) 19.06 (9.8-37.1) 0.54 (0.3-0.9) 23.82 (6.6-86.5)  9.16 (3.7-22.7) 
    Ptrend 0.004 <0.0001 0.01 <0.001  <0.001 
Concerns of future health       
    Concerned  1.00  1.00  1.00 
    Not concerned  4.05 (1.8-9.3)  9.69 (2.1-45.3)  2.92 (1.1-7.5) 
Current health status       
    Good 1.00 1.00 1.00    
    Fair/poor 1.89 (1.3-2.7) 0.51 (0.3-0.97) 2.06 (1.3-3.4)    
Exposure to cyclosporin A       
    No exposure    1.00   
    Exposed    0.36 (0.2-0.7)   
Exposure to TBI       
    No exposure     1.00  
    Exposed     1.64 (1.0-2.7)  
Risk factorsEntire cohort
Allogeneic HCT
Autologous HCT
GPECancer/HCT–related visitGPECancer/HCT–related visitGPECancer/HCT–related visit
Type of transplant       
    Autologous 1.00 1.00     
    Allogeneic 1.72 (1.1-2.6) 0.49 (0.3-0.9)     
Race       
    Non-Hispanic White  1.00  1.00   
    Hispanic White  0.23 (0.1-0.6)  0.16 (0.04-0.6)   
    Others  0.67 (0.3-1.7)  0.66 (0.2-2.1)   
Follow-up years       
    2-5 1.00 1.00 1.00 1.00  1.00 
    6-10 0.65 (0.5-0.9) 5.15 (2.7-9.7) 0.44 (0.3-0.8) 6.82 (1.9-24.5)  4.75 (2.3-10.1) 
    11+ 0.57 (0.4-0.9) 19.06 (9.8-37.1) 0.54 (0.3-0.9) 23.82 (6.6-86.5)  9.16 (3.7-22.7) 
    Ptrend 0.004 <0.0001 0.01 <0.001  <0.001 
Concerns of future health       
    Concerned  1.00  1.00  1.00 
    Not concerned  4.05 (1.8-9.3)  9.69 (2.1-45.3)  2.92 (1.1-7.5) 
Current health status       
    Good 1.00 1.00 1.00    
    Fair/poor 1.89 (1.3-2.7) 0.51 (0.3-0.97) 2.06 (1.3-3.4)    
Exposure to cyclosporin A       
    No exposure    1.00   
    Exposed    0.36 (0.2-0.7)   
Exposure to TBI       
    No exposure     1.00  
    Exposed     1.64 (1.0-2.7)  
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept